233 related articles for article (PubMed ID: 21832257)
1. A bioluminogenic HDAC activity assay: validation and screening.
Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
[TBL] [Abstract][Full Text] [Related]
2. A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening.
Ciossek T; Julius H; Wieland H; Maier T; Beckers T
Anal Biochem; 2008 Jan; 372(1):72-81. PubMed ID: 17868634
[TBL] [Abstract][Full Text] [Related]
3. A visible wavelength spectrophotometric assay suitable for high-throughput screening of 3-hydroxy-3-methylglutaryl-CoA synthase.
Andrew Skaff D; Miziorko HM
Anal Biochem; 2010 Jan; 396(1):96-102. PubMed ID: 19706283
[TBL] [Abstract][Full Text] [Related]
4. A substrate-independent TR-FRET histone deacetylase inhibitor assay.
Marks BD; Fakhoury SA; Frazee WJ; Eliason HC; Riddle SM
J Biomol Screen; 2011 Dec; 16(10):1247-53. PubMed ID: 21940713
[TBL] [Abstract][Full Text] [Related]
5. Identification of selective class II histone deacetylase inhibitors using a novel dual-parameter binding assay based on fluorescence anisotropy and lifetime.
Haus P; Korbus M; Schröder M; Meyer-Almes FJ
J Biomol Screen; 2011 Dec; 16(10):1206-16. PubMed ID: 22027638
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylases.
Huang Y; Shaw PG; Davidson NE
Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous screening assay for human tankyrase.
Narwal M; Fallarero A; Vuorela P; Lehtiö L
J Biomol Screen; 2012 Jun; 17(5):593-604. PubMed ID: 22357873
[TBL] [Abstract][Full Text] [Related]
8. TR-FRET cellular assays for interrogating posttranslational modifications of histone H3.
Machleidt T; Robers MB; Hermanson SB; Dudek JM; Bi K
J Biomol Screen; 2011 Dec; 16(10):1236-46. PubMed ID: 21972037
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer.
Riester D; Hildmann C; Schwienhorst A; Meyer-Almes FJ
Anal Biochem; 2007 Mar; 362(1):136-41. PubMed ID: 17250798
[TBL] [Abstract][Full Text] [Related]
10. False HDAC Inhibition by Aurone Compound.
Itoh Y; Suzuki M; Matsui T; Ota Y; Hui Z; Tsubaki K; Suzuki T
Chem Pharm Bull (Tokyo); 2016; 64(8):1124-8. PubMed ID: 27477650
[TBL] [Abstract][Full Text] [Related]
11. A microplate reader-based nonisotopic histone deacetylase activity assay.
Heltweg B; Jung M
Anal Biochem; 2002 Mar; 302(2):175-83. PubMed ID: 11878795
[TBL] [Abstract][Full Text] [Related]
12. Eosin Y as an internal standard for a plate reader-based quantitation of a histone deacetylase substrate.
Heltweg B; Jung M
Arch Pharm (Weinheim); 2002 Jun; 335(6):296-300. PubMed ID: 12210773
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors in cancer therapy.
Lane AA; Chabner BA
J Clin Oncol; 2009 Nov; 27(32):5459-68. PubMed ID: 19826124
[TBL] [Abstract][Full Text] [Related]
14. High-throughput assays for sirtuin enzymes: a microfluidic mobility shift assay and a bioluminescence assay.
Liu Y; Gerber R; Wu J; Tsuruda T; McCarter JD
Anal Biochem; 2008 Jul; 378(1):53-9. PubMed ID: 18358225
[TBL] [Abstract][Full Text] [Related]
15. Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay.
Plant M; Dineen T; Cheng A; Long AM; Chen H; Morgenstern KA
Anal Biochem; 2011 Dec; 419(2):217-27. PubMed ID: 21855527
[TBL] [Abstract][Full Text] [Related]
16. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Biochemical Analysis of Classical Histone Deacetylases.
Villagra A; Sahakian E; Seto E
Methods Enzymol; 2016; 573():161-81. PubMed ID: 27372753
[TBL] [Abstract][Full Text] [Related]
18. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
19. An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.
Falk H; Connor T; Yang H; Loft KJ; Alcindor JL; Nikolakopoulos G; Surjadi RN; Bentley JD; Hattarki MK; Dolezal O; Murphy JM; Monahan BJ; Peat TS; Thomas T; Baell JB; Parisot JP; Street IP
J Biomol Screen; 2011 Dec; 16(10):1196-205. PubMed ID: 22086725
[TBL] [Abstract][Full Text] [Related]
20. Identification of HDAC Inhibitors Using a Cell-Based HDAC I/II Assay.
Hsu CW; Shou D; Huang R; Khuc T; Dai S; Zheng W; Klumpp-Thomas C; Xia M
J Biomol Screen; 2016 Jul; 21(6):643-52. PubMed ID: 26858181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
